These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12177110)

  • 1. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
    Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
    J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
    Metayer C; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; Joensuu T; van Leeuwen FE; van't Veer MB; Curtis RE; Holowaty EJ; Andersson M; Wiklund T; Gospodarowicz M; Travis LB
    J Clin Oncol; 2000 Jun; 18(12):2435-43. PubMed ID: 10856104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.
    Hodgson DC; Gilbert ES; Dores GM; Schonfeld SJ; Lynch CF; Storm H; Hall P; Langmark F; Pukkala E; Andersson M; Kaijser M; Joensuu H; Fosså SD; Travis LB
    J Clin Oncol; 2007 Apr; 25(12):1489-97. PubMed ID: 17372278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
    J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
    van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
    J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S; Robison LL; Oberlin O; Greenberg M; Bunin G; Fossati-Bellani F; Meadows AT
    N Engl J Med; 1996 Mar; 334(12):745-51. PubMed ID: 8592547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
    Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
    J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancers following pediatric Hodgkin's disease.
    Wolden SL; Lamborn KR; Cleary SF; Tate DJ; Donaldson SS
    J Clin Oncol; 1998 Feb; 16(2):536-44. PubMed ID: 9469338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second malignancies after Hodgkin's disease: the Munich experience.
    Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
    Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
    Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT;
    J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.